Hubra Pharmaceuticals Private Limited, a active private limited company, was established on 17 March 2016 in Chennai, Tamil Nadu, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U74900TN2016PTC104726. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹4.85 M.
It upholds a compliant status. Employing 20 professional, Its leadership includes Pondavakkam Vijaya Arunagirinathan (Director), Pondavakkam Arunagirinathan Arunodhayan (Managing Director), Pondahavakkam Arunodayan Priya (Director). Past directors included Veerasamy Sanjeevikumar. It holds ₹3.06 Cr open charges and ₹1.00 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at New No. 12/1, Old No. 22/1,Minor Trustpuram, 1St Cross Street, Trustpuram, Kodambakka, M, Chennai, Tamil Nadu, 600024.
U74900TN2016PTC104726
104726
17 March 2016
₹5.00 M
₹4.85 M
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Hubra Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pondavakkam Vijaya Arunagirinathan | Director | 17 Mar 2016 | Current |
| Pondavakkam Arunagirinathan Arunodhayan | Managing Director | 21 Apr 2016 | Current |
| Pondahavakkam Arunodayan Priya | Director | 17 Mar 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 20 Jan 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Hubra Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 48.09% increase. The company also saw a substantial improvement in profitability, with a 99.83% increase in profit. The company's net worth Soared by an impressive increase of 23.31%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Hubra Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹30,598,000.00
₹10,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Dec 2020 | Hdfc Bank Limited | ₹3.06 Cr | Open |
| 17 Sep 2018 | Indian Overseas Bank | ₹1.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Hubra Pharmaceuticals has a workforce of 20 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Hubra Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hubra Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Hdfc Bank Limited of Rs. 30.60 M registered on 15 Dec 2020 with Charge ID 100403844 was modified on 03 Oct 2025. was recorded as a recent event.
Progress on Hubra Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Hubra Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was completed.
A charge registered on 17 Sep 2018 via Charge ID 100226743 with Indian Overseas Bank was fully satisfied on 08 Mar 2021. was recorded as a recent event.
The activity A charge with Hdfc Bank Limited amounted to Rs. 30.60 M with Charge ID 100403844 was registered on 15 Dec 2020. was completed.
The activity A charge with Indian Overseas Bank amounted to Rs. 10.00 M with Charge ID 100226743 was registered on 17 Sep 2018. was completed.
The CIN of Hubra Pharmaceuticals Private Limited is U74900TN2016PTC104726.
Hubra Pharmaceuticals Private Limited is headquartered at New No. 12/1, Old No. 22/1,Minor Trustpuram, 1St Cross Street, Trustpuram, Kodambakka, M, Chennai, Tamil Nadu, 600024.
Hubra Pharmaceuticals Private Limited was incorporated on 17 March 2016.
The current directors of Hubra Pharmaceuticals Private Limited are
The primary industry of Hubra Pharmaceuticals Private Limited is Trade.
Hubra Pharmaceuticals Private Limited is unlisted.
The authorized capital of Hubra Pharmaceuticals Private Limited is ₹5.00 M, and the paid-up capital is ₹4.85 M.
The compliance status of Hubra Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX